# PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis

> **NCT00005005** · PHASE2 · COMPLETED · sponsor: **Dennis Black** · enrollment: 238 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** PTH
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT00005005
- **Lead sponsor:** Dennis Black
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2013-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005005, "PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00005005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*